Global Glucagon Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 95

Published Date: 02 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Glucagon market size was valued at USD 572.1 million in 2023 and is forecast to a readjusted size of USD 851 million by 2030 with a CAGR of 5.8% during review period.

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.

The Global Info Research report includes an overview of the development of the Glucagon industry chain, the market status of Emergency Kits (Inject Glucagon, Nasal Glucagon), General Use (Inject Glucagon, Nasal Glucagon), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Glucagon.

Regionally, the report analyzes the Glucagon markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Glucagon market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Glucagon market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Glucagon industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Inject Glucagon, Nasal Glucagon).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Glucagon market.

Regional Analysis: The report involves examining the Glucagon market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Glucagon market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Glucagon:
Company Analysis: Report covers individual Glucagon manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Glucagon This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Emergency Kits, General Use).

Technology Analysis: Report covers specific technologies relevant to Glucagon. It assesses the current state, advancements, and potential future developments in Glucagon areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Glucagon market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Glucagon market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Inject Glucagon
Nasal Glucagon

Market segment by Application
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others

Major players covered
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glucagon product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Glucagon, with price, sales, revenue and global market share of Glucagon from 2019 to 2024.
Chapter 3, the Glucagon competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucagon breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Glucagon market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Glucagon.
Chapter 14 and 15, to describe Glucagon sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Glucagon
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Glucagon Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Inject Glucagon
        1.3.3 Nasal Glucagon
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Glucagon Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Emergency Kits
        1.4.3 General Use
        1.4.4 Diagnostic & Motility
        1.4.5 Cardiogenic Shock
        1.4.6 Others
    1.5 Global Glucagon Market Size & Forecast
        1.5.1 Global Glucagon Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Glucagon Sales Quantity (2019-2030)
        1.5.3 Global Glucagon Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Novo Nordisk
        2.1.1 Novo Nordisk Details
        2.1.2 Novo Nordisk Major Business
        2.1.3 Novo Nordisk Glucagon Product and Services
        2.1.4 Novo Nordisk Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Novo Nordisk Recent Developments/Updates
    2.2 Eli Lilly
        2.2.1 Eli Lilly Details
        2.2.2 Eli Lilly Major Business
        2.2.3 Eli Lilly Glucagon Product and Services
        2.2.4 Eli Lilly Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Eli Lilly Recent Developments/Updates
    2.3 Fresenius Kabi
        2.3.1 Fresenius Kabi Details
        2.3.2 Fresenius Kabi Major Business
        2.3.3 Fresenius Kabi Glucagon Product and Services
        2.3.4 Fresenius Kabi Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Fresenius Kabi Recent Developments/Updates
    2.4 Torrent Labs
        2.4.1 Torrent Labs Details
        2.4.2 Torrent Labs Major Business
        2.4.3 Torrent Labs Glucagon Product and Services
        2.4.4 Torrent Labs Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Torrent Labs Recent Developments/Updates
    2.5 Taj Pharmaceuticals
        2.5.1 Taj Pharmaceuticals Details
        2.5.2 Taj Pharmaceuticals Major Business
        2.5.3 Taj Pharmaceuticals Glucagon Product and Services
        2.5.4 Taj Pharmaceuticals Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Taj Pharmaceuticals Recent Developments/Updates
    2.6 Xeris Pharmaceuticals
        2.6.1 Xeris Pharmaceuticals Details
        2.6.2 Xeris Pharmaceuticals Major Business
        2.6.3 Xeris Pharmaceuticals Glucagon Product and Services
        2.6.4 Xeris Pharmaceuticals Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Xeris Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Glucagon by Manufacturer
    3.1 Global Glucagon Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Glucagon Revenue by Manufacturer (2019-2024)
    3.3 Global Glucagon Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Glucagon by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Glucagon Manufacturer Market Share in 2023
        3.4.2 Top 6 Glucagon Manufacturer Market Share in 2023
    3.5 Glucagon Market: Overall Company Footprint Analysis
        3.5.1 Glucagon Market: Region Footprint
        3.5.2 Glucagon Market: Company Product Type Footprint
        3.5.3 Glucagon Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Glucagon Market Size by Region
        4.1.1 Global Glucagon Sales Quantity by Region (2019-2030)
        4.1.2 Global Glucagon Consumption Value by Region (2019-2030)
        4.1.3 Global Glucagon Average Price by Region (2019-2030)
    4.2 North America Glucagon Consumption Value (2019-2030)
    4.3 Europe Glucagon Consumption Value (2019-2030)
    4.4 Asia-Pacific Glucagon Consumption Value (2019-2030)
    4.5 South America Glucagon Consumption Value (2019-2030)
    4.6 Middle East and Africa Glucagon Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Glucagon Sales Quantity by Type (2019-2030)
    5.2 Global Glucagon Consumption Value by Type (2019-2030)
    5.3 Global Glucagon Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Glucagon Sales Quantity by Application (2019-2030)
    6.2 Global Glucagon Consumption Value by Application (2019-2030)
    6.3 Global Glucagon Average Price by Application (2019-2030)

7 North America
    7.1 North America Glucagon Sales Quantity by Type (2019-2030)
    7.2 North America Glucagon Sales Quantity by Application (2019-2030)
    7.3 North America Glucagon Market Size by Country
        7.3.1 North America Glucagon Sales Quantity by Country (2019-2030)
        7.3.2 North America Glucagon Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Glucagon Sales Quantity by Type (2019-2030)
    8.2 Europe Glucagon Sales Quantity by Application (2019-2030)
    8.3 Europe Glucagon Market Size by Country
        8.3.1 Europe Glucagon Sales Quantity by Country (2019-2030)
        8.3.2 Europe Glucagon Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Glucagon Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Glucagon Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Glucagon Market Size by Region
        9.3.1 Asia-Pacific Glucagon Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Glucagon Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Glucagon Sales Quantity by Type (2019-2030)
    10.2 South America Glucagon Sales Quantity by Application (2019-2030)
    10.3 South America Glucagon Market Size by Country
        10.3.1 South America Glucagon Sales Quantity by Country (2019-2030)
        10.3.2 South America Glucagon Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Glucagon Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Glucagon Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Glucagon Market Size by Country
        11.3.1 Middle East & Africa Glucagon Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Glucagon Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Glucagon Market Drivers
    12.2 Glucagon Market Restraints
    12.3 Glucagon Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Glucagon and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Glucagon
    13.3 Glucagon Production Process
    13.4 Glucagon Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Glucagon Typical Distributors
    14.3 Glucagon Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Glucagon Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Glucagon Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
    Table 4. Novo Nordisk Major Business
    Table 5. Novo Nordisk Glucagon Product and Services
    Table 6. Novo Nordisk Glucagon Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Novo Nordisk Recent Developments/Updates
    Table 8. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 9. Eli Lilly Major Business
    Table 10. Eli Lilly Glucagon Product and Services
    Table 11. Eli Lilly Glucagon Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Eli Lilly Recent Developments/Updates
    Table 13. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
    Table 14. Fresenius Kabi Major Business
    Table 15. Fresenius Kabi Glucagon Product and Services
    Table 16. Fresenius Kabi Glucagon Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Fresenius Kabi Recent Developments/Updates
    Table 18. Torrent Labs Basic Information, Manufacturing Base and Competitors
    Table 19. Torrent Labs Major Business
    Table 20. Torrent Labs Glucagon Product and Services
    Table 21. Torrent Labs Glucagon Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Torrent Labs Recent Developments/Updates
    Table 23. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 24. Taj Pharmaceuticals Major Business
    Table 25. Taj Pharmaceuticals Glucagon Product and Services
    Table 26. Taj Pharmaceuticals Glucagon Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Taj Pharmaceuticals Recent Developments/Updates
    Table 28. Xeris Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 29. Xeris Pharmaceuticals Major Business
    Table 30. Xeris Pharmaceuticals Glucagon Product and Services
    Table 31. Xeris Pharmaceuticals Glucagon Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Xeris Pharmaceuticals Recent Developments/Updates
    Table 33. Global Glucagon Sales Quantity by Manufacturer (2019-2024) & (K MT)
    Table 34. Global Glucagon Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 35. Global Glucagon Average Price by Manufacturer (2019-2024) & (USD/MT)
    Table 36. Market Position of Manufacturers in Glucagon, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 37. Head Office and Glucagon Production Site of Key Manufacturer
    Table 38. Glucagon Market: Company Product Type Footprint
    Table 39. Glucagon Market: Company Product Application Footprint
    Table 40. Glucagon New Market Entrants and Barriers to Market Entry
    Table 41. Glucagon Mergers, Acquisition, Agreements, and Collaborations
    Table 42. Global Glucagon Sales Quantity by Region (2019-2024) & (K MT)
    Table 43. Global Glucagon Sales Quantity by Region (2025-2030) & (K MT)
    Table 44. Global Glucagon Consumption Value by Region (2019-2024) & (USD Million)
    Table 45. Global Glucagon Consumption Value by Region (2025-2030) & (USD Million)
    Table 46. Global Glucagon Average Price by Region (2019-2024) & (USD/MT)
    Table 47. Global Glucagon Average Price by Region (2025-2030) & (USD/MT)
    Table 48. Global Glucagon Sales Quantity by Type (2019-2024) & (K MT)
    Table 49. Global Glucagon Sales Quantity by Type (2025-2030) & (K MT)
    Table 50. Global Glucagon Consumption Value by Type (2019-2024) & (USD Million)
    Table 51. Global Glucagon Consumption Value by Type (2025-2030) & (USD Million)
    Table 52. Global Glucagon Average Price by Type (2019-2024) & (USD/MT)
    Table 53. Global Glucagon Average Price by Type (2025-2030) & (USD/MT)
    Table 54. Global Glucagon Sales Quantity by Application (2019-2024) & (K MT)
    Table 55. Global Glucagon Sales Quantity by Application (2025-2030) & (K MT)
    Table 56. Global Glucagon Consumption Value by Application (2019-2024) & (USD Million)
    Table 57. Global Glucagon Consumption Value by Application (2025-2030) & (USD Million)
    Table 58. Global Glucagon Average Price by Application (2019-2024) & (USD/MT)
    Table 59. Global Glucagon Average Price by Application (2025-2030) & (USD/MT)
    Table 60. North America Glucagon Sales Quantity by Type (2019-2024) & (K MT)
    Table 61. North America Glucagon Sales Quantity by Type (2025-2030) & (K MT)
    Table 62. North America Glucagon Sales Quantity by Application (2019-2024) & (K MT)
    Table 63. North America Glucagon Sales Quantity by Application (2025-2030) & (K MT)
    Table 64. North America Glucagon Sales Quantity by Country (2019-2024) & (K MT)
    Table 65. North America Glucagon Sales Quantity by Country (2025-2030) & (K MT)
    Table 66. North America Glucagon Consumption Value by Country (2019-2024) & (USD Million)
    Table 67. North America Glucagon Consumption Value by Country (2025-2030) & (USD Million)
    Table 68. Europe Glucagon Sales Quantity by Type (2019-2024) & (K MT)
    Table 69. Europe Glucagon Sales Quantity by Type (2025-2030) & (K MT)
    Table 70. Europe Glucagon Sales Quantity by Application (2019-2024) & (K MT)
    Table 71. Europe Glucagon Sales Quantity by Application (2025-2030) & (K MT)
    Table 72. Europe Glucagon Sales Quantity by Country (2019-2024) & (K MT)
    Table 73. Europe Glucagon Sales Quantity by Country (2025-2030) & (K MT)
    Table 74. Europe Glucagon Consumption Value by Country (2019-2024) & (USD Million)
    Table 75. Europe Glucagon Consumption Value by Country (2025-2030) & (USD Million)
    Table 76. Asia-Pacific Glucagon Sales Quantity by Type (2019-2024) & (K MT)
    Table 77. Asia-Pacific Glucagon Sales Quantity by Type (2025-2030) & (K MT)
    Table 78. Asia-Pacific Glucagon Sales Quantity by Application (2019-2024) & (K MT)
    Table 79. Asia-Pacific Glucagon Sales Quantity by Application (2025-2030) & (K MT)
    Table 80. Asia-Pacific Glucagon Sales Quantity by Region (2019-2024) & (K MT)
    Table 81. Asia-Pacific Glucagon Sales Quantity by Region (2025-2030) & (K MT)
    Table 82. Asia-Pacific Glucagon Consumption Value by Region (2019-2024) & (USD Million)
    Table 83. Asia-Pacific Glucagon Consumption Value by Region (2025-2030) & (USD Million)
    Table 84. South America Glucagon Sales Quantity by Type (2019-2024) & (K MT)
    Table 85. South America Glucagon Sales Quantity by Type (2025-2030) & (K MT)
    Table 86. South America Glucagon Sales Quantity by Application (2019-2024) & (K MT)
    Table 87. South America Glucagon Sales Quantity by Application (2025-2030) & (K MT)
    Table 88. South America Glucagon Sales Quantity by Country (2019-2024) & (K MT)
    Table 89. South America Glucagon Sales Quantity by Country (2025-2030) & (K MT)
    Table 90. South America Glucagon Consumption Value by Country (2019-2024) & (USD Million)
    Table 91. South America Glucagon Consumption Value by Country (2025-2030) & (USD Million)
    Table 92. Middle East & Africa Glucagon Sales Quantity by Type (2019-2024) & (K MT)
    Table 93. Middle East & Africa Glucagon Sales Quantity by Type (2025-2030) & (K MT)
    Table 94. Middle East & Africa Glucagon Sales Quantity by Application (2019-2024) & (K MT)
    Table 95. Middle East & Africa Glucagon Sales Quantity by Application (2025-2030) & (K MT)
    Table 96. Middle East & Africa Glucagon Sales Quantity by Region (2019-2024) & (K MT)
    Table 97. Middle East & Africa Glucagon Sales Quantity by Region (2025-2030) & (K MT)
    Table 98. Middle East & Africa Glucagon Consumption Value by Region (2019-2024) & (USD Million)
    Table 99. Middle East & Africa Glucagon Consumption Value by Region (2025-2030) & (USD Million)
    Table 100. Glucagon Raw Material
    Table 101. Key Manufacturers of Glucagon Raw Materials
    Table 102. Glucagon Typical Distributors
    Table 103. Glucagon Typical Customers
List of Figures
    Figure 1. Glucagon Picture
    Figure 2. Global Glucagon Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Glucagon Consumption Value Market Share by Type in 2023
    Figure 4. Inject Glucagon Examples
    Figure 5. Nasal Glucagon Examples
    Figure 6. Global Glucagon Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Glucagon Consumption Value Market Share by Application in 2023
    Figure 8. Emergency Kits Examples
    Figure 9. General Use Examples
    Figure 10. Diagnostic & Motility Examples
    Figure 11. Cardiogenic Shock Examples
    Figure 12. Others Examples
    Figure 13. Global Glucagon Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global Glucagon Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global Glucagon Sales Quantity (2019-2030) & (K MT)
    Figure 16. Global Glucagon Average Price (2019-2030) & (USD/MT)
    Figure 17. Global Glucagon Sales Quantity Market Share by Manufacturer in 2023
    Figure 18. Global Glucagon Consumption Value Market Share by Manufacturer in 2023
    Figure 19. Producer Shipments of Glucagon by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 20. Top 3 Glucagon Manufacturer (Consumption Value) Market Share in 2023
    Figure 21. Top 6 Glucagon Manufacturer (Consumption Value) Market Share in 2023
    Figure 22. Global Glucagon Sales Quantity Market Share by Region (2019-2030)
    Figure 23. Global Glucagon Consumption Value Market Share by Region (2019-2030)
    Figure 24. North America Glucagon Consumption Value (2019-2030) & (USD Million)
    Figure 25. Europe Glucagon Consumption Value (2019-2030) & (USD Million)
    Figure 26. Asia-Pacific Glucagon Consumption Value (2019-2030) & (USD Million)
    Figure 27. South America Glucagon Consumption Value (2019-2030) & (USD Million)
    Figure 28. Middle East & Africa Glucagon Consumption Value (2019-2030) & (USD Million)
    Figure 29. Global Glucagon Sales Quantity Market Share by Type (2019-2030)
    Figure 30. Global Glucagon Consumption Value Market Share by Type (2019-2030)
    Figure 31. Global Glucagon Average Price by Type (2019-2030) & (USD/MT)
    Figure 32. Global Glucagon Sales Quantity Market Share by Application (2019-2030)
    Figure 33. Global Glucagon Consumption Value Market Share by Application (2019-2030)
    Figure 34. Global Glucagon Average Price by Application (2019-2030) & (USD/MT)
    Figure 35. North America Glucagon Sales Quantity Market Share by Type (2019-2030)
    Figure 36. North America Glucagon Sales Quantity Market Share by Application (2019-2030)
    Figure 37. North America Glucagon Sales Quantity Market Share by Country (2019-2030)
    Figure 38. North America Glucagon Consumption Value Market Share by Country (2019-2030)
    Figure 39. United States Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Canada Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Mexico Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 42. Europe Glucagon Sales Quantity Market Share by Type (2019-2030)
    Figure 43. Europe Glucagon Sales Quantity Market Share by Application (2019-2030)
    Figure 44. Europe Glucagon Sales Quantity Market Share by Country (2019-2030)
    Figure 45. Europe Glucagon Consumption Value Market Share by Country (2019-2030)
    Figure 46. Germany Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. France Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. United Kingdom Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Russia Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Italy Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. Asia-Pacific Glucagon Sales Quantity Market Share by Type (2019-2030)
    Figure 52. Asia-Pacific Glucagon Sales Quantity Market Share by Application (2019-2030)
    Figure 53. Asia-Pacific Glucagon Sales Quantity Market Share by Region (2019-2030)
    Figure 54. Asia-Pacific Glucagon Consumption Value Market Share by Region (2019-2030)
    Figure 55. China Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Japan Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Korea Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. India Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. Southeast Asia Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. Australia Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. South America Glucagon Sales Quantity Market Share by Type (2019-2030)
    Figure 62. South America Glucagon Sales Quantity Market Share by Application (2019-2030)
    Figure 63. South America Glucagon Sales Quantity Market Share by Country (2019-2030)
    Figure 64. South America Glucagon Consumption Value Market Share by Country (2019-2030)
    Figure 65. Brazil Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 66. Argentina Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 67. Middle East & Africa Glucagon Sales Quantity Market Share by Type (2019-2030)
    Figure 68. Middle East & Africa Glucagon Sales Quantity Market Share by Application (2019-2030)
    Figure 69. Middle East & Africa Glucagon Sales Quantity Market Share by Region (2019-2030)
    Figure 70. Middle East & Africa Glucagon Consumption Value Market Share by Region (2019-2030)
    Figure 71. Turkey Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Egypt Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Saudi Arabia Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. South Africa Glucagon Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 75. Glucagon Market Drivers
    Figure 76. Glucagon Market Restraints
    Figure 77. Glucagon Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Glucagon in 2023
    Figure 80. Manufacturing Process Analysis of Glucagon
    Figure 81. Glucagon Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals

Related Reports

Global Glucagon Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Glucagon Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Global Glucagon Supply, Demand and Key Producers, 2024-2030

Global Glucagon Supply, Demand and Key Producers, 2024-2030

date 09 Feb 2024

date Pharma & Healthcare

The global Glucagon market size is expected to reach $ 851 million by 2030, rising at a market growth of 5.8% CAGR during the forecast period (2024-2030).

Product Tags

Glucagon

Glucagon Like Peptide-1 (GLP-1) Agonists

Glucagon Injectable

Glucagon-like peptide 1 (GLP-1)-based Therapies

Antidiabetic Glucagon-like Peptide 1 Agonists

Glucagon Like Peptide 2 Receptor

Glucagon-like Peptide-2 (GLP-2) Agonist

Glucagon Drug

Glucagon Injection

Glucagon-like Peptide-1 Receptor Agonist

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>